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To fabricate functional shape of drug delivery system (DDS), various processes are used. In 
this research, based on layered manufacturing, two different processes of 1) replication and 2) 
direct deposition were used to fabricate scaffold type implantable DDS. For replication process, 
hot embossing process for fabrication of patterned layers and bonding for construction of three-
dimensional shape were used. As a direct deposition process, nano composite deposition system 
(NCDS) was used. Various scaffolds were fabricated with different filament size, pore size, and 
shape. It is observed that the scaffold type of implantable DDS is more stable than non-porous 
DDS through the in vivo test. 
 
Introduction 
Drug delivery system (DDS) refers to formulation of the drug, its delivery vehicle, and its 
method of administration. Nowadays many drug delivery systems have been studied, and for 
effective delivery of drugs, implantable drug delivery systems have been introduced. Implantable 
DDS has many advantages in less side effects, small number of doses/injections, controlled 
release, etc. Figure 1 shows the comparison of conventional drug delivery (left) and controlled 




Figure 1. Comparison of conventional drug delivery (left) and controlled drug delivery (right) 
 
Many researchers have been studying to fabricate functional structures using various types of 
materials to control the release of drug. Using the advantages of various micro-fabrication 
technologies, various implant DDSs were fabricated with various materials such as PZT (lead 
zirconate titanate), silicon, and polymers [1-6]. Although these DDSs give a good control in drug 
release, DDSs need to be removed after the drug is completely released. Biodegradable materials, 
on the other hand, such as, polycaprolactone (PCL), polylactic acid, polyglycolic acid and their 
co polymer poly(lactic/glycolic) acid (PLGA) are removed over long time without additional 
surgery.   
For implantable DDS, it is important to control the release of the drug. Moreover, this DDS 
needs to avoid immune system from the host. In this research, porous structure as the shape of 
DDS and composite material to control the release of drug were used to fabricate implantable 
DDS. 
Based on layered manufacturing (LM) many rapid prototyping (RP) technologies are 
introduced to fabricate complicated 3-dimensional structures. Fabricating layer by layer, it is easy 
to fabricate porous (scaffold in this research) structure as well as complicated structures. Two 
different processes of replication and direct deposition were used as the fabrication process in this 
research. Various scaffolds were fabricated and tested in vivo environment. 
 
Materials 
Composition of materials 
To fabricate implantable DDS, the materials were formed into drug-polymer composite. 5-
flurouracil (5-FU), which is an anti-cancer drug, was used as drug. Hydorxyapatite (HA) particle 
was used as additive to control the drug release. As a matrix, PLGA(85:15) was used to combine 
the drug and HA particles. These two particles and polymer were mechanically mixed at 120 ℃ 
into the raw DDS material. PLGA has about two years of degradation time and amorphous 
melting temperature. 5-FU melts at 280~282℃ and HA is a bio-ceramic. Through the in vitro test, 
drug concentration was measured using HPLC (High Performance Liquid Chromatograph 




Using the micro-fabrication processes, various shapes of DDS were fabricated. In this paper, 
the replication and direct deposition processes were used as the micro-fabrication process. 
 
Replication method 
For replication process, hot embossing and bonding processes were used. Hot embossing 
process has an advantage in fabrication of patterned structures. To fabricate patterned structure 
for scaffold DDS, the micro mold tool was designed (figure 2 (a)). The designed mold tool has 
draft angel to have an advantage in demolding (figure 2 (b)). Figure 2 (c) shows the picture of 
micro machined micro mold. The tool was micro machined on the brass plate using micro 
endmill with diameter of 100 µm.  
 
 
Figure 2. A schematic diagram of designed micro mold for hot embossing process and micro 
machined micro mold 
To construct three-dimensional shape, patterned layers by hot embossing were stacked and 
bonded each other by thermal bonding process. Figure 3 shows the fabricated implantable DDS 




Figure 3. A implantable DDS using replication process 
 
Direct deposition method 
Nano composite deposition system (NCDS) was used as direct deposition process to fabricate 
scaffold shape [7]. NCDS has a hybrid process which is combined machining and deposition 
process. In this research, only deposition process was used with  300 µm micro nozzle and 1 µm 
resolution of 3-axis micro-stage. Molten (120℃) drug-polymer composite material was deposited 
at the controlled position in the three-dimensional space. Figure 4 show the NCDS hardware with 









Figure 5. A sequence of fabrication process of three-dimensional scaffold structure [8] 
 
Evaluation 
To evaluate the structure, the specimens were tested in vivo environment. Through the two 
weeks in vivo test, the changes of shape were observed using optical micro scope (Sometech, 
ICS-305B, Korea). Three different shape of implant DDS were compared. Cylindrical DDS 
without pore, cylinder-shape scaffold, and hexahedron-shape scaffold were implanted into the 
Sprague-dawley rat. Each specimen was implanted into the back of rat, and extracted and 




Figure 6. A sequence of implantation, extraction, and collection of DDS [9] 
 
Results 
Through the test, their morphological changes in the in vivo environment were measured as 
shown in figure 7. The effect of pressure inside the body markedly altered the morphology of the 
non-porous DDS. The DDS with the 200-µm pore size more-or-less maintained its shape over 
two weeks of implantation. The hexahedron-shape DDS maintained almost the same dimensions 
as its original shape. This might be affected by the body fluid in the pores inside of DDS. Figure 
8 shows the cumulative amount of released drug in vivo environment that indicates cylinder-




Figure 7. Implanted DDS after two weeks of in vivo test, (a and b) reference, (c and d) 




Figure 8. Cumulative amount of released drug in vivo environment for 2 weeks 
 
Conclusions 
To fabricate porous structure as implantable DDS, based on LM, two different fabrication 
processes were used. Using the replication process and direct deposition process, three different 
types of DDS were fabricated and evaluated in vivo environment of rat. Scaffold DDS was more 
stable in vivo environment. The replication process has an advantage in mass production while 
direct deposition process has an advantage in fabrication of complicated shapes. 
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